The Genetics of Parkinson Disease

被引:212
|
作者
Bekris, Lynn M. [1 ,2 ]
Mata, Ignacio F. [1 ,3 ]
Zabetian, Cyrus P. [1 ,3 ]
机构
[1] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
genetics; neurodegeneration; Parkinson disease; ALPHA-SYNUCLEIN GENE; EARLY-ONSET PARKINSONISM; AUTOSOMAL-DOMINANT PARKINSONISM; RECESSIVE JUVENILE PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; PATHOGENIC DJ-1 MUTATIONS; GENOME-WIDE ASSOCIATION; MAPT H1 HAPLOTYPE; PINK1; MUTATIONS; LRRK2; G2019S;
D O I
10.1177/0891988710383572
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Parkinson disease (PD) is the second most common neurodegenerative disorder. In most instances, PD is thought to result from a complex interaction between multiple genetic and environmental factors, though rare monogenic forms of the disease do exist. Mutations in 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP13A2) have conclusively been shown to cause familial parkinsonism. In addition, common variation in 3 genes (MAPT, LRRK2, and SNCA) and loss-of-function mutations in GBA have been well-validated as susceptibility factors for PD. The function of these genes and their contribution to PD pathogenesis remain to be fully elucidated. The prevalence, incidence, clinical manifestations, and genetic components of PD are discussed in this review.
引用
收藏
页码:228 / 242
页数:15
相关论文
共 50 条
  • [41] Genetics of Parkinson's disease
    Gasser, T
    JOURNAL OF NEUROLOGY, 2001, 248 (10) : 833 - 840
  • [42] Genetic risk factors in Parkinson's disease
    Billingsley, K. J.
    Bandres-Ciga, S.
    Saez-Atienzar, S.
    Singleton, A. B.
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 9 - 20
  • [43] Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
    Bandres-Ciga, Sara
    Diez-Fairen, Monica
    Jeff Kim, Jonggeol
    Singleton, Andrew B.
    NEUROBIOLOGY OF DISEASE, 2020, 137
  • [44] Progresses in Parkinson's disease genetics: What lessons have we learnt?
    Courtin, T.
    Brice, A.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2022, 206 (07): : 902 - 908
  • [45] Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
    Huang, Yue
    Wei, Jun
    Cooper, Antony
    Morris, Margaret J.
    GENES & DISEASES, 2023, 10 (03) : 786 - 798
  • [46] Psychosis in Parkinson's Disease: A Lesson from Genetics
    Angelopoulou, Efthalia
    Bougea, Anastasia
    Papageorgiou, Sokratis G.
    Villa, Chiara
    GENES, 2022, 13 (06)
  • [47] Parkinson's disease: Exit toxins, enter genetics
    Westerlund, Marie
    Hoffer, Barry
    Olson, Lars
    PROGRESS IN NEUROBIOLOGY, 2010, 90 (02) : 146 - 156
  • [48] Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes
    Crosiers, David
    Theuns, Jessie
    Cras, Patrick
    Van Broeckhoven, Christine
    JOURNAL OF CHEMICAL NEUROANATOMY, 2011, 42 (02) : 131 - 141
  • [49] Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study
    Tan, Manuela M. X.
    Malek, Naveed
    Lawton, Michael A.
    Hubbard, Leon
    Pittman, Alan M.
    Joseph, Theresita
    Hehir, Jason
    Swallow, Diane M. A.
    Grosset, Katherine A.
    Marrinan, Sarah L.
    Bajaj, Nin
    Barker, Roger A.
    Burn, David J.
    Bresner, Catherine
    Foltynie, Thomas
    Hardy, John
    Wood, Nicholas
    Ben-Shlomo, Yoav
    Grosset, Donald G.
    Williams, Nigel M.
    Morris, Huw R.
    BRAIN, 2019, 142 : 2828 - 2844
  • [50] Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy
    Paccosi, Elena
    Proietti-De-Santis, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)